Reply #18: My outlook on this as a Type 1 for 45 years

[IDemo]

I've seen so many research 'breakthroughs' over the decades, but the news stories all ended with the same disclaimer as this one: "Don't get your hopes up too soon".

Part of the problem is that mice aren't miniature humans. While they may share the same basic organ physiology as we, experiments that work well in the lab don't automatically guarantee success with human patients.

A huge delay is introduced because of FDA testing requirements. From this link: "From beginning to end, it can take as long as 15 years to produce an FDA-approved drug." And, - "Only about 10 percent of the drugs that are developed ever make it to market."

From another post of mine on this topic:

Many seem convinced that pharmaceutical companies will attempt to roadblock any diabetes cure because of the profits they currently enjoy with insulin and blood glucose monitoring equipment. Big Pharma won't stifle this, but they are businesses, after all. If this works at all with humans, I'm inclined to believe that pharmaceutical companies will extract the greatest possible profit from this neither by shelving it nor making it a permanent cure, but by engineering it to function as a 'maintenance medication'. The results of the testing on mice indicated a degree of variability on the effective timespan: "Some have remained in that state for as long as four months, with just one injection."

If it is determined that the only 'safe treatment' winds up being annual or bi-annual injections, profits will remain in place and patients will (mostly) be happy.